May 4, 2020 / 9:46 AM / a month ago

BRIEF-Celon Pharma Gets 31.2 Mln Zloty Subsidy From NCBR For Project Development

May 4 (Reuters) - Celon Pharma SA:

* TOTAL COST OF PROJECT REALIZATION IS 55.6 MILLION ZLOTYS

* SUBSIDY IS FOR SEROTONERGIC ANALGESIC THERAPY BASED ON 5-HT7 RECEPTOR AGONIST (STEP7) PROJECT Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below